{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-041494","form_type":"8-K","ticker":"SRXH","cik":"0001471727","company_name":"SRx Health Solutions, Inc.","filed_at":"2024-10-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.531344+00:00","generated_at":"2026-05-30T12:45:22.557747+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Better Choice expects combined 2025 revenue ~$270M, EBITDA ~$10M; SRx Health acquisition close imminent","bullets":["Combined 2025 pro forma revenue over $270M and EBITDA over $10M, based on management assumptions.","Transaction expected to close late Q4 2024 or early Q1 2025; all-stock deal valued at ~$125M.","Combined TTM revenue $235M (+25% QoQ); expected annual cost savings ~$1.7M.","Better Choice Q2 2024 adjusted EBITDA near break-even (-$0.03M); SRx Health had CAD$180M revenue in 2023.","Pro forma fully diluted shares 22.9M; insiders own ~75%; net tangible book value $4.07/share."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-041494","json":"https://secwatch.observer/filing/0001493152-24-041494.json","markdown":"https://secwatch.observer/filing/0001493152-24-041494.md","text":"https://secwatch.observer/filing/0001493152-24-041494.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1471727/000149315224041494/0001493152-24-041494-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1471727/000149315224041494/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T12:45:22.557747+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}